What if treating extremely preterm babies with their own (i.e., autologous) cord blood stem cells could reduce their increased risk of brain damage and related conditions? Using a patient’s own cord blood stem cells to treat neurological conditions, like cerebral...
The FDA made history in April with its first-ever approval of an expanded cord blood product for use as a primary treatment in hematopoietic stem cell transplants (HSCT) for certain blood cancers in adults and children 12 years of age and older.1 Why is cord...
Last year was a busy one for our group’s newborn stem cell labs and storage facilities in North America. A steady stream of families contacted our team, requesting the release of their stored newborn stem cell samples for use in stem cell transplant procedures or...
Robin Roberts, co-anchor of ABC’s “Good Morning America,” recently shared the story of a fellow cancer survivor,¹ Kirsten Riemer. While both Robin and Kirsten can trace their successful treatments to a stem cell transplant, there’s a big difference in their stories....
November is World Prematurity Month, which is dedicated to raising awareness of preterm birth. Preterm birth is the delivery of a baby prior to 37 weeks gestation – or more than 3 weeks prior to the due date. Staying pregnant to full term is one of the best ways to...
Share this article : Researchers have announced that newborn stem cells played a key role in the successful treatment of pulmonary arterial hypertension (PAH) – a rare and often life-threatening disease that causes high blood pressure in the arteries of the lung and...
